Summary
HOPES of a new treatment for a rare form of multiple sclerosis have been shattered with the rejection of a drug.
Fingolimod, which focuses on treating those with so-called remitting relapsing multiple sclerosis, has been rejected by the National Institute for Health and Clinical Excellence after a recent assessment.See the full content of this document
Extract
Frustration As New Ms Drug Is Rejected
For MS sufferer Louise Leach, 49, of Pittville, it is just the latest in a series of betrayals from N...
See the full content of this document
Sponsored links
